Straits Times Index
3,388.52 +7.68 (+0.23%) S&P 500
4,117.86 -46.14 (-1.11%) Dow
33,949.01 -207.68 (-0.61%) Nasdaq
11,910.52 -203.27 (-1.68%) BTC-USD
22,959.10 -303.00 (-1.30%) CMC Crypto 200
529.21 -7.68 (-1.43%)
ABT May 2023 90.000 put
| Previous close | 0.5200 |
| Open | 0.5200 |
| Bid | 0.5800 |
| Ask | 0.6500 |
| Strike | 90.00 |
| Expiry date | 2023-05-19 |
| Day's range | 0.5200 - 0.5200 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.22k |
- Motley Fool
3 Dividend Stocks That Will Hold Up No Matter the Market Conditions
All three major indexes have started the year off on the right foot. After touching bear territory last year, they're now posting gains for 2023 so far. Will the next step be a bull market? It's possible -- but it's too early to say whether the market is truly ready to fully recover and thrive.
- Motley Fool
Baby Formula Blues Hit Abbott Laboratories Stock Hard in 2022. Can It Rebound in 2023?
Abbott Laboratories (NYSE: ABT) has generally been a good investment to hold over the years. Is Abbott a bad-news buy that could turn things around in 2023, or has this once-safe healthcare stock become too risky of an investment to be holding right now? Last month, Abbott reported its fourth-quarter and year-end results for 2022.
- Motley Fool
Is This Dividend King a Buy for Income Investors?
No matter which way the market goes, the payouts of companies with decades of dividend growth behind them tend to go in one direction: up. Abbott Laboratories' (NYSE: ABT) 50-year dividend growth streak makes it one of just 43 Dividend Kings. With 113,000 employees and a presence in more than 160 countries, Abbott is among the largest healthcare companies in the world.
